This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07064/identifier/pdb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07064/identifier/pubchem-compound/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07064/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07064/identifier/drugbank/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://linked.opendata.cz/resource/drugbank/drug/DB07064/identifier/chemspider/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07064
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB07064 n7:DB07064
dcterms:title
(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE
adms:identifier
n10:5257024 n11:6857690 n12:99443535 n13:DB07064 n14:3QC
n3:IUPAC-Name
n4:271B4630-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4636-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4635-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4632-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4633-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4634-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B462E-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B462F-363D-11E5-9242-09173F13E4C5 n4:271B462C-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B462D-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B463C-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B463D-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4637-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4638-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B463A-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4639-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B463B-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4642-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4644-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4645-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4641-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4640-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4643-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4631-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B463E-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B463F-363D-11E5-9242-09173F13E4C5